Safety and effects of SGLT-2 inhibitor use among LVAD patients with type 2 diabetes mellitus

被引：7

作者：

Cagliostro, Matthew ^{[1
]}

Hundal, Prabhjot ^{[2
]}

Ting, Peter ^{[1
]}

Patel, Sonika ^{[1
]}

Sudarshan, Sangita ^{[2
]}

Thomas, Jordan ^{[2
]}

Morris, Kathleen ^{[2
]}

Mancini, Donna M. ^{[1
,3
,4
]}

Moss, Noah ^{[1
,3
]}

Lala, Anuradha ^{[1
,3
,4
]}

Ravichandran, Ashwin ^{[2
]}

Mitter, Sumeet S. ^{[1
,3
,5
]}

机构：

[1] Icahn Sch Med Mt Sinai, Mt Sinai Hosp, New York, NY 10029 USA

[2] Ascens St Vincent, Indianapolis, IN USA

[3] Mt Sinai Hosp, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA

[4] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY USA

[5] 1190 5th Ave,Box 1030, New York, NY 10029 USA

来源：

AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE | 2022年 / 18卷

关键词：

SGLT2 inhibitors (SGLT2i); Heart failure; Left ventricular assist device (LVAD);

D O I：

10.1016/j.ahjo.2022.100154

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SGLT-2 inhibitors have been shown to confer reduced risk of adverse cardiovascular events in patients with heart failure, and have also been studied preliminarily among heart transplant patients, with overall positive findings. Use of SGLT-2 inhibitors among patients with durable mechanical circulatory support has not been studied. Here we present our results from a combined retrospective cohort of LVAD patients on SGLT-2 inhibitors at two major academic centers, which showed a good safety profile but prompted questions for further investigation. We advocate for further research into the safety and impact of SGLT-2 inhibitors among LVAD patients.

引用

页数：4

共 10 条

[1] Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure [J].

Bhatt, Deepak L. ;

Szarek, Michael ;

Steg, P. Gabriel ;

Cannon, Christopher P. ;

Leiter, Lawrence A. ;

McGuire, Darren K. ;

Lewis, Julia B. ;

Riddle, Matthew C. ;

Voors, Adriaan A. ;

Metra, Marco ;

Lund, Lars H. ;

Komajda, Michel ;

Testani, Jeffrey M. ;

Wilcox, Christopher S. ;

Ponikowski, Piotr ;

Lopes, Renato D. ;

Verma, Subodh ;

Lapuerta, Pablo ;

Pitt, Bertram .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02) :117-128

[2] Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients [J].

Cehic, Matthew G. ;

Muir, Christopher A. ;

Greenfield, Jerry R. ;

Hayward, Christopher ;

Jabbour, Andrew ;

Keogh, Anne ;

Kotlyar, Eugene ;

Muthiah, Kavitha ;

Macdonald, Peter S. .

TRANSPLANTATION DIRECT, 2019, 5 (05)

[3] 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [J].

Lawton, Jennifer S. ;

Tamis-Holland, Jacqueline E. ;

Bangalore, Sripal ;

Bates, Eric R. ;

Beckie, Theresa M. ;

Bischoff, James M. ;

Bittl, John A. ;

Cohen, Mauricio G. ;

DiMaio, J. Michael ;

Don, Creighton W. ;

Fremes, Stephen E. ;

Gaudino, Mario F. ;

Goldberger, Zachary D. ;

Grant, Michael C. ;

Jaswal, Jang B. ;

Kurlansky, Paul A. ;

Mehran, Roxana ;

Metkus, Thomas S. Jr Jr ;

Nnacheta, Lorraine C. ;

Rao, Sunil, V ;

Sellke, Frank W. ;

Sharma, Garima ;

Yong, Celina M. ;

Zwischenberger, Brittany A. .

CIRCULATION, 2022, 145 (03) :E18-E114

[4] 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction A Report of the American College of Cardiology Solution Set Oversight Committee [J].

Maddox, Thomas M. ;

Januzzi, James L. ;

Allen, Larry A. ;

Breathett, Khadijah ;

Butler, Javed ;

Davis, Leslie L. ;

Fonarow, Gregg C. ;

Ibrahim, Nasrien E. ;

Lindenfeld, JoAnn ;

Masoudi, Frederick A. ;

Motiwala, Shweta R. ;

Oliveros, Estefania ;

Patterson, J. Herbert ;

Walsh, Mary Norine ;

Wasserman, Alan ;

Yancy, Clyde W. ;

Youmans, Quentin R. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (06) :772-810

[5] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction [J].

McMurray, J. J. V. ;

Solomon, S. D. ;

Inzucchi, S. E. ;

Kober, L. ;

Kosiborod, M. N. ;

Martinez, F. A. ;

Ponikowski, P. ;

Sabatine, M. S. ;

Anand, I. S. ;

Belohlavek, J. ;

Bohm, M. ;

Chiang, C. -E. ;

Chopra, V. K. ;

de Boer, R. A. ;

Desai, A. S. ;

Diez, M. ;

Drozdz, J. ;

Dukat, A. ;

Ge, J. ;

Howlett, J. G. ;

Katova, T. ;

Kitakaze, M. ;

Ljungman, C. E. A. ;

Merkely, B. ;

Nicolau, J. C. ;

O'Meara, E. ;

Petrie, M. C. ;

Vinh, P. N. ;

Schou, M. ;

Tereshchenko, S. ;

Verma, S. ;

Held, C. ;

DeMets, D. L. ;

Docherty, K. F. ;

Jhund, P. S. ;

Bengtsson, O. ;

Sjostrand, M. ;

Langkilde, A. -M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21) :1995-2008

[6] A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report [J].

Mehra, M. R. ;

Uriel, N. ;

Naka, Y. ;

Cleveland, J. C., Jr. ;

Yuzefpolskaya, M. ;

Salerno, C. T. ;

Walsh, M. N. ;

Milano, C. A. ;

Patel, C. B. ;

Hutchins, S. W. ;

Ransom, J. ;

Ewald, G. A. ;

Itoh, A. ;

Raval, N. Y. ;

Silvestry, S. C. ;

Cogswell, R. ;

John, R. ;

Bhimaraj, A. ;

Bruckner, B. A. ;

Lowes, B. D. ;

Um, J. Y. ;

Jeevanandam, V. ;

Sayer, G. ;

Mangi, A. A. ;

Molina, E. J. ;

Sheikh, F. ;

Aaronson, K. ;

Pagani, F. D. ;

Cotts, W. G. ;

Tatooles, A. J. ;

Babu, A. ;

Chomsky, D. ;

Katz, J. N. ;

Tessmann, P. B. ;

Dean, D. ;

Krishnamoorthy, A. ;

Chuang, J. ;

Topuria, I. ;

Sood, P. ;

Goldstein, D. J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (17) :1618-1627

[7] Empagliflozin in the management of diabetes mellitus after cardiac transplantation [J].

Muir, Christopher A. ;

Greenfield, Jerry R. ;

MacDonald, Peter S. .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (08) :914-916

[8] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes [J].

Neal, Bruce ;

Perkovic, Vlado ;

Mahaffey, Kenneth W. ;

de Zeeuw, Dick ;

Fulcher, Greg ;

Erondu, Ngozi ;

Shaw, Wayne ;

Law, Gordon ;

Desai, Mehul ;

Matthews, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07) :644-657

[9] Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure [J].

Packer, Milton ;

Anker, Stefan D. ;

Butler, Javed ;

Filippatos, Gerasimos ;

Pocock, Stuart J. ;

Carson, Peter ;

Januzzi, James ;

Verma, Subodh ;

Tsutsui, Hiroyuki ;

Brueckmann, Martina ;

Jamal, Waheed ;

Kimura, Karen ;

Schnee, Janet ;

Zeller, Cordula ;

Cotton, Daniel ;

Bocchi, Edimar ;

Boehm, Michael ;

Choi, Dong-Ju ;

Chopra, Vijay ;

Chuquiure, Eduardo ;

Giannetti, Nadia ;

Janssens, Stefan ;

Zhang, Jian ;

Juanatey, Jose R. Gonzalez ;

Kaul, Sanjay ;

Brunner-La Rocca, Hans-Peter ;

Merkely, Bela ;

Nicholls, Stephen J. ;

Perrone, Sergio ;

Pina, Ileana ;

Ponikowski, Piotr ;

Sattar, Naveed ;

Senni, Michele ;

Seronde, Marie-France ;

Spinar, Jindrich ;

Squire, Iain ;

Taddei, Stefano ;

Wanner, Christoph ;

Zannad, Faiez .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) :1413-1424

[10] Effects of GLP-1 receptor agonists and SGLT-2 inhibitors in heart transplant patients with type 2 diabetes: Initial report from a cardiometabolic center of excellence [J].

Sammour, Yasser ;

Nassif, Michael ;

Magwire, Melissa ;

Thomas, Merrill ;

Fendler, Timothy ;

Khumri, Taiyeb ;

Sperry, Brett W. ;

O'Keefe, James ;

Kosiborod, Mikhail .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (06) :426-429

← 1 →